Parkinsons Disease Home > Cogentin Drug Information

The U.S. Food and Drug Administration (FDA) has approved Cogentin® (benztropine mesylate) for the treatment of:
The brand-name tablets are no longer available, although the injectable version still is. Generic versions of Cogentin tablets are made by various manufacturers.
Most people tolerate this medicine well; however, safety information on Cogentin should be reviewed with your healthcare provider so you are aware of possible side effects and potential drug interactions, and so you know what to do to avoid complications.
(Click Cogentin for more information on this drug, including when and how to take it, factors that affect your dose, and what to do if you are pregnant or breastfeeding.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.